|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||
| Cash and cash equivalents | |||||||||||||||
| Restricted cash | |||||||||||||||
| Investments: | |||||||||||||||
| Held-to-maturity debt securities, at amortized cost (net of allowance for credit losses of $5 at June 30, 2024 and $125 at December 31, 2023) | |||||||||||||||
| Available-for-sale debt securities, at fair value (amortized cost $41,978 at June 30, 2024 and $58,516 at December 31, 2023) | |||||||||||||||
| Equity securities, at fair value (cost $2,000 in 2020) | |||||||||||||||
| Mortgage loans | |||||||||||||||
| Other invested assets | |||||||||||||||
| Total investments | |||||||||||||||
| Receivables (net of allowance for credit losses of $1,463 at March 31, 2023 and $1,488 at December 31, 2022) | |||||||||||||||
| Trade and other receivables (net of allowance for credit losses of $2,024 at June 30, 2024 and $1,802 at December 31, 2023) | |||||||||||||||
| Prepaid expenses, deposits and other assets | |||||||||||||||
| Lease right-of-use assets | |||||||||||||||
| Fixed assets (net of accumulated depreciation of $33,991 at June 30, 2024 and $26,272 at December 31, 2023) | |||||||||||||||
| Title plants | |||||||||||||||
| Goodwill | |||||||||||||||
| Trade names (net of accumulated amortization of $3,187 at December 31, 2020) | |||||||||||||||
| Assets held for disposal | |||||||||||||||
| Total assets | |||||||||||||||
| Liabilities and stockholders’ deficit | |||||||||||||||
| Accounts payable | |||||||||||||||
| Accrued expenses and other liabilities | |||||||||||||||
| Lease liabilities | |||||||||||||||
| Loan and Security Agreement, net of debt issuance costs and original issue discount | |||||||||||||||
| Loan from a related party | |||||||||||||||
| Liability for loss and loss adjustment expenses | |||||||||||||||
| Warrant liabilities | |||||||||||||||
| Sponsor Covered Shares liability | |||||||||||||||
| Liabilities held for disposal | |||||||||||||||
| Total liabilities | |||||||||||||||
| Stockholders’ deficit: | |||||||||||||||
| Preferred stock | |||||||||||||||
| Preferred Stock Series A | |||||||||||||||
| Preferred Stock Series A-2 | |||||||||||||||
| Preferred Stock Series A-1 | |||||||||||||||
| Preferred Stock Series A-2 | |||||||||||||||
| Preferred Stock Series B | |||||||||||||||
| Preferred Stock Series C | |||||||||||||||
| Common stock, 0.0001 par value; 80,000,000 shares authorized at June 30, 2024; 14,074,805 and 13,524,203 shares issued and outstanding as of June 30, 2024 and December 31, 2023, respectively | |||||||||||||||
| Total common stock, 0.0001 par value; 80,000,000 shares authorized at June 30, 2024; 14,074,805 and 13,524,203 shares issued and outstanding as of June 30, 2024 and December 31, 2023, respectively | |||||||||||||||
| Additional paid-in capital | |||||||||||||||
| Accumulated deficit | |||||||||||||||
| Accumulated other comprehensive income | |||||||||||||||
| Total stockholders’ deficit | |||||||||||||||
| Total liabilities and stockholders’ deficit | |||||||||||||||
Loading...